Apellis Pharmaceuticals
APLS
$51.50
Share price
-0.56%
Change (1 day)
-37.23%
Change (1 year)
Categories
Operating Margin for Apellis Pharmaceuticals (APLS)
Operating Margin as of April 2024 (TTM): -356.37%
According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -356.37%. At the end of 2022 the company had an Operating Margin of -820.55%.
Operating Margin history for Apellis Pharmaceuticals from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -820.55% | -25.46% |
| 2021 | -1,100.85% | 781.29% |
| 2020 | -124.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.